Healthcare -
Biotechnology - NASDAQ - US
$ 1.48
-10.8 %
$ 4.09 M
Market Cap
-0.11
P/E
PALI - GROSS PROFIT
Gross Profit PALI - Palisade Bio, Inc.
250 K
LAST VALUE
86.76%
2 YEAR CAGR
-27.52%
5 YEAR CAGR
8.56%
10 YEAR CAGR